The authors concluded that blockage of the VEGFR2 can stop neovascularization and reduce the primary tumor but can, at the same time, lead to increased co‐option of preexistent cerebral blood vessels, disease spreading and therefore defeat the original object of achieve treatment.44, 45, 69, 70, 71, 72. The gene discussed is KDR; the disease is neoplasm.